Takashi Seto

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Thoracic cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, Chang-Min Choi, Nong Yang, Geoffrey Liu, Enriqueta Felip Font, Maurice Pérol, Benjamin Besse, Jorge J Nieva, Luis E Raez, Nathan A Pennell, Anastasios Dimou, Filippo de Marinis, Fortunato Ciardiello, Takashi Seto, Zheyi Hu, Max Pan, Weiqing Wang, Shuanglian Li, Sai-Hong Ignatius Ou
TRUST-II: a global phase II study of taletrectinib in ROS1 -positive non-small-cell lung cancer and other solid tumors. Future oncology (London, England) (2023)
Hirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi, Kiyotaka Yoh, Haruhiro Saito, Shunichi Sugawara, Koji Yamazaki, Kazuhiko Nakagawa, Kenji Sugio, Takashi Seto, Shinichi Toyooka, Hiroshi Date, Tetsuya Mitsudomi, Yasuto Yoneshima, Kohei Yokoi, Hideo Saka, Hiroaki Okamoto, Yuichi Takiguchi, Toshiaki Takahashi, Masahiro Tsuboi
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Minoru Fukuda, Masafumi Yamaguchi, Takuya Yamazaki, Soichiro Funaki, Hiroshi Mukae, Junya Fukuoka, Kazuki Nabeshima, Hisashi Tateyama, Kazuto Ashizawa, Noriyuki Tomiyama, Masaki Hara, Takashi Seto, Meinoshin Okumura, Kenji Sugio
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study. Thoracic cancer 13 (17) (2022)
Takashi Seto, Kaname Nosaki, Mototsugu Shimokawa, Ryo Toyozawa, Shunichi Sugawara, Hidetoshi Hayashi, Haruyasu Murakami, Terufumi Kato, Seiji Niho, Hideo Saka, Masahide Oki, Hiroshige Yoshioka, Isamu Okamoto, Haruko Daga, Koichi Azuma, Hiroshi Tanaka, Kazumi Nishino, Rie Tohnai, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study). Journal for immunotherapy of cancer 10 (2) (2022)
George D Demetri, Filippo De Braud, Alexander E Drilon, Salvatore Siena, Manish R Patel, Byoung Chul Cho, Stephen V Liu, Myung-Ju Ahn, Chao-Hua Chiu, Jessica J Lin, Koichi Goto, Jeeyun Lee, Lyudmila Bazhenova, Thomas John, Marwan Fakih, Sant P Chawla, Rafal Dziadziuszko, Takashi Seto, Sebastian Heinzmann, Bethany Pitcher, David Chen, Timothy R Wilson, Christian Rolfo
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Taichi Matsubara, Shinkichi Takamori, Takatoshi Fujishita, Ryo Toyozawa, Kensaku Ito, Masafumi Yamaguchi, Takashi Seto, Tatsuro Okamoto
Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy. Thoracic cancer 12 (23) (2021)
Shinkichi Takamori, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Ryo Toyozawa, Takashi Seto, Masafumi Yamaguchi, Tatsuro Okamoto
Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation. Thoracic cancer 12 (6) (2021)
Shinkichi Takamori, Nobuki Furubayashi, Kenichi Taguchi, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Masafumi Yamaguchi, Ryo Toyozawa, Takashi Seto, Takahito Negishi, Motonobu Nakamura, Tatsuro Okamoto
Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab. Thoracic cancer 12 (14) (2021)
Kazuhiko Nakagawa, Ernest Nadal, Edward B Garon, Makoto Nishio, Takashi Seto, Nobuyuki Yamamoto, Keunchil Park, Jin-Yuan Shih, Luis Paz-Ares, Bente Frimodt-Moller, Annamaria H Zimmermann, Sameera Wijayawardana, Carla Visseren-Grul, Martin Reck, null null
RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Kyriakos P Papadopoulos, Erkut Hasan Borazanci, Alice T Shaw, Ryohei Katayama, Yuki Shimizu, Viola W Zhu, Thomas Yang Sun, Heather A Wakelee, Russell W Madison, Alexa B Schrock, Giorgio Senaldi, Naoki Nakao, Hiroyuki Hanzawa, Masaya Tachibana, Takeshi Isoyama, Kenji Nakamaru, Chenhui Deng, Meijing Li, Frank Fan, Qinying Zhao, Yanfei Gao, Takashi Seto, Pasi A Jänne, Sai-Hong Ignatius Ou
U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Shinkichi Takamori, Takashi Seto, Mikako Jinnouchi, Taichi Matsubara, Naoki Haratake, Naoko Miura, Ryo Toyozawa, Masafumi Yamaguchi, Mitsuhiro Takenoyama
Brain cavernous hemangioma mimicking radiation-induced necrosis in a patient with non-small cell lung cancer. Thoracic cancer 11 (7) (2020)
Shinkichi Takamori, Mitsuhiro Takenoyama, Taichi Matsubara, Takatoshi Fujishita, Kensaku Ito, Masafumi Yamaguchi, Ryo Toyozawa, Takashi Seto, Tatsuro Okamoto
Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient. Thoracic cancer 11 (12) (2020)
Makoto Nishio, Toshiaki Takahashi, Hiroshige Yoshioka, Kazuhiko Nakagawa, Tatsuro Fukuhara, Kazuhiko Yamada, Masao Ichiki, Hiroshi Tanaka, Takashi Seto, Hiroshi Sakai, Kazuo Kasahara, Miyako Satouchi, Shi Rong Han, Kazuo Noguchi, Takashi Shimamoto, Terufumi Kato
KEYNOTE-025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1-positive advanced non-small-cell lung cancer. Cancer science 110 (3) (2019)
Naoki Haratake, Takashi Seto, Shinkichi Takamori, Ryo Toyozawa, Kaname Nosaki, Naoko Miura, Taro Ohba, Gouji Toyokawa, Kenichi Taguchi, Masafumi Yamaguchi, Mototsugu Shimokawa, Mitsuhiro Takenoyama
Short progression-free survival of ALK inhibitors sensitive to secondary mutations in ALK-positive NSCLC patients. Thoracic cancer 10 (9) (2019)
Taito Esaki, Fumihiko Hirai, Akitaka Makiyama, Takashi Seto, Hideaki Bando, Yoichi Naito, Kiyotaka Yoh, Kae Ishihara, Tomoyuki Kakizume, Kazuto Natsume, Andrea Myers, Toshihiko Doi
Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors. Cancer science 110 (4) (2019)
Haruyasu Murakami, Hiroshi Nokihara, Hidetoshi Hayashi, Takashi Seto, Keunchil Park, Koichi Azuma, Chun-Ming Tsai, James Chih-Hsin Yang, Makoto Nishio, Sang-We Kim, Katsuyuki Kiura, Akira Inoue, Koji Takeda, Jin-Hyoung Kang, Tomoki Nakagawa, Kentaro Takeda, Rio Akazawa, Yuichiro Kaneko, Masashi Shimazaki, Satoshi Morita, Masahiro Fukuoka, Kazuhiko Nakagawa
Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations. Cancer science 109 (9) (2018)